Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Is a |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 5 mg/mL eye drops |
Is a |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 1% single-use eye drops |
Is a |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 0.5% single-use eye drops |
Is a |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 1% preservative-free eye drops |
Is a |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride + phenylephrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 0.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 0.5% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 0.5% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 1% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 1% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
2 |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 20 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 20 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyclopentolate hydrochloride |
Inferred relationship |
Some |
1 |